Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the-shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera's versatile platform shows promise in broader immunomodulation applications. 

Biotechnology

Health Care

Therapeutics

Esphera SynBio Inc

The Ottawa office focuses on scientific research and financial strategy, supporting innovation and fiscal oversight.

Ottawa

Brian Lichty

Egidio Nascimento

This department conducts scientific research and experimentation to advance knowledge and innovation.

Research Science

This department provides strategic direction and overall management of the organization.

Esphera SynBio Inc

Org chart

Teams

Research Science

Executive Leadership

Offices

Esphera SynBio Inc

Org chart

Teams

Research Science

Executive Leadership

Offices

Related companies